London Daily

Focus on the big picture.
Friday, Sep 11, 2026

Dr. Sanjay Gupta on medical marijuana: We are in an age of wisdom, but also an age of foolishness

We have made great strides with medical marijuana, but we've also repeated some of the same mistakes that led cannabis to be vilified and misunderstood in the first place. Hype and echo chambers are never a friend to science or clear-eyed thinking.

When we released "Weed" in 2013, few people had ever heard of cannabidiol, or CBD. Now, two-thirds of Americans are familiar with the compound, and 1 in 7 have tried it. Most of the country, 93%, are in favor of medical marijuana and hemp-derived CBD itself, which has less than 0.3% THC, has been legalized in every state.

It's not just public perception. The science over the last six years has grown by leaps and bounds, as well. Epidiolex, a pharmaceutical-grade CBD oil, went through clinical trials and is being prescribed for thousands of patients with seizures. The founder of GW Pharmaceuticals, the maker of Epidiolex, told me they are now developing cannabis medications for everything from autism to anxiety.

The lives of characters we introduced you to in "Weed" have completely changed, as well. The Stanley brothers of Colorado - who literally bet the farm on CBD and couldn't even afford a reliable car six years ago - now grow CBD on 800 acres in three states and have a marijuana empire worth an estimated $2 billion.

And Charlotte, sweet Charlotte Figi. Soon after birth, she started having seizures. By age 3, she was having 300 seizures a week, despite having tried more than half a dozen medications. Her mother, Paige, worried her daughter would stop breathing one day or go into cardiac arrest. Charlotte was not expected to live past her 8th birthday. Today, she's 12, and has only two or three seizures a month, despite being off all of her other seizure medications. The only thing she takes is a CBD oil, called Charlotte's Web. She represents countless patients who are alive today because of this plant, and this plant alone.

For many in the medical marijuana community, these last few years have been the realization of a dream they never really believed was possible. But, there is a funny thing about dreams. As beautiful as they are, they are often fragile and ready to tear at the seams.

Here is where the cannabis story took an awkward, ill-conceived and sometimes ugly turn.


A bold promise, hijacked

Last year, in a single moment, the legislation around CBD, a non-psychoactive component of cannabis, changed. With the passage of the Farm Bill, hemp, defined as any cannabis plant with 0.3% THC or less, became legal to grow, sell, and consume. For the cannabis community, it was like suddenly drinking from a fire hose in the middle of a drought. One day, it was taboo wrapped in decades of stigma, and now it is sold at the corner store.

There are CBD-infused oils, mints, cheeseburgers, vitamin waters, shampoos and even sportswear. Most of this stuff couldn't possibly offer the human body any benefit. Without the respect of being treated like the medicine it is, or reasonable regulation when it is purchased as a supplement, CBD has been hijacked by unscrupulous actors peddling crooked, corrupt and contaminated products. They're making a quick buck and disappearing into the ether without a trace.

It was really discouraging to see the results of a recent study in the medical journal JAMA where researchers analyzed 84 CBD products from 31 companies and found 69% were mislabeled. Some of the products had no CBD at all, some had too much CBD, some too much THC.

Others studies showed that some CBD products contained dangerous synthetics that have been responsible for outbreaks of illness all over the country. The legitimate vendors of CBD, who took the time to ensure consistency, safety and quality, are now sadly lumped together with the dishonest and dodgy ones, leaving the consumer confused about where to turn.

The general attitude we have long heard from CBD consumers is they think the product "might help, can't hurt, why not." But, when you can't even count on the authenticity or safety of the product you are buying, that is no longer the case.

In our latest investigation, "Weed 5: The CBD Craze," we take you on board the cannabis rocket ship, that shot us from a barren wasteland of prohibition to the Wild West of the CBD craze, and we reveal exactly how we got here. We also provide a roadmap to help you navigate the landscape of CBD, including understanding how to read a "certificate of analysis" and determining what is legal and what isn't.


A story of facts, not faith

With the release of my first "Weed" documentary and op-ed in 2013, some say I became an advocate for medical marijuana. At first I recoiled. To me and my journalist friends and colleagues, "advocacy" can be a dirty word. No doubt, it is sometimes necessary, to champion causes that would otherwise get little attention. To some, however, advocacy implies a certain lack of objectivity, a blind faith. Is that what happened with "Weed"?

There's one thing I can't stress enough: The core story of cannabis has never required me or anyone else to follow blindly. With medical marijuana, you aren't asked to sacrifice your objectivity or your skepticism. You too will discover it if you diligently study the evidence from all over the world, spend days in the lab to really understand the cannabis molecules - and visit patients whose lives truly depend on it.

The real story of cannabis has always been rooted in facts, not faith.

With the series of "Weed," films, I wanted to shine a light on what would have been obvious, if people had taken the time to look. Echo chambers exist, even in the world of science. I wanted to show you that these chambers can grow bigger and louder with each generation that neglects to challenge them. For too long, the real story of cannabis was drowned out in those echo chambers. Marijuana was preordained as having "no currently accepted medical use and a high potential for abuse" despite plenty of evidence to the contrary. My team and I wanted you to hear the other side, the voices that had been drowned out by decades of this noise.


Let science lead the way

Over the last six years, I have continued to read constantly, discuss the latest scientific developments with researchers and spend hours with patients to really understand their experience with cannabis as a medication. Through it all, however, there has been something else nagging at me.

I realized that CBD has become such a convenient political narrative, so easy to rally behind. Maybe too easy.

Indeed, CBD alone doesn't make you high. You don't have to smoke it. And the people it has helped the most are little kids like Charlotte. But that was never supposed to be the entire story. After all, "Weed" wasn't just about CBD, it was about weed, the entire cannabis plant, comprised of hundreds of potentially therapeutic ingredients. And yes, one of those is THC, which to this day remains demonized with the rest of the cannabis plant as a federally illegal (Schedule 1) substance, even though it too has shown promise as an effective medicine.

We are in an age of wisdom, but also an age of foolishness. We have made great strides with medical marijuana, but we've also repeated some of the same mistakes that led cannabis to be vilified and misunderstood in the first place. Hype and echo chambers are never a friend to science or clear-eyed thinking.

Make no mistake: Cannabis is a medicine. Over the last six years, through countless articles and essays, and now five documentary films, my team and I have made that case and we have provided the proof. At times, it can heal when nothing else can. Denying people this substance represents a moral issue just as much as a medical one.

I have always let science and facts lead the way. That isn't advocacy; that is speaking truth to power. But yes, when you are certain of the evidence and people's lives depend on it, then shout it from the rooftops, trumpet it loudly in medical conferences and make sure the world knows. If being called an advocate means you took the time to faithfully learn the issues, allowed yourself to change and even admit where you were wrong, then I will proudly own the title and honorably wear the badge.

Newsletter

Related Articles

0:00
0:00
Close
John Lewis Partnership Loss Widens to £124 Million
UK Government to Put White Working-Class Social Mobility at Centre of Equality Policy
McLaren Plans £450 Million Technology Investment Creating 1,000 UK Jobs
UK Chancellor Faces Calls for Wealth Taxes and Public Ownership in Autumn Budget
English Mayors to Gain Powers to Impose Uncapped Overnight Tourist Taxes
JPMorgan’s Jamie Dimon Warns UK Government Against Bank Windfall Taxes
UK Air Traffic Control Outage Cancels More Than 2,000 Flights
UK Imposes Trade Ban on Israeli Settlements in the West Bank
UK Borrowing Costs Surge as Middle East Tensions Push Long-Term Gilt Yields to Highest Since 1998
Buckingham Palace Says Prince Harry and Meghan Will Not Resume Official Royal Duties
UK Treasury Faces Calls to Scrap £100,000 Childcare Support Threshold
Trades Union Congress Urges Labour Government to Rewrite Migration Policy
Riot Police Deployed After Anti-Migrant Protests Turn Violent in Portsmouth
UK Considers Replacing Some Disability Cash Payments With Direct Services
JPMorgan’s Jamie Dimon Warns UK Chancellor Against Higher Banking Taxes
UK Announces New Sanctions Targeting Israeli Settlements in West Bank
Metropolitan Police Investigate Alleged Illegal Donations to Reform UK
UK Charges Wiltshire Man With Assisting Russian Intelligence
UK Orders Urgent Review After Air Traffic Failure Cancels More Than 2,000 Flights
Merz Rebukes AfD Expansion in Saxony-Anhalt
King Charles Confirms Prince Harry and Meghan Will Remain Private Citizens
Labour Selects Former Child Refugee for By-Election in Keir Starmer’s Former Seat
Foreign Private Equity Accelerates Takeovers of London-Listed Industrial Companies
NHS Maternity Care Faces Scrutiny Over Support for Mothers After Caesarean Births
BBC Warns Staff Strikes Are Likely Amid Job Cuts and Programme Cancellations
English Housing Affordability Improves to Best Level in More Than a Decade
UK Health Commission Proposes Framework for Wider AI Adoption Across NHS
Labour Faces Pressure for Wealth Tax Ahead of Autumn Budget
Metropolitan Police Open Criminal Investigation Into Alleged Foreign Donations to Reform UK
UK Police Deploy Riot Officers After Anti-Immigration Unrest in Portsmouth and Dover
UK Defends Sanctions on Israeli Settlements Despite Diplomatic Retaliation
UK Air Traffic Control Failure Cancels More Than 1,000 Flights and Disrupts 65,000 Passengers
Compass Urges £10 Million Wealth Tax and Public Ownership Ahead of UK Autumn Budget
UK Government’s Devolution Plans Face House of Lords Scrutiny
Maldives Seeks New Chagos Sovereignty Talks With UK Prime Minister Andy Burnham
UK Airports Face Continuing Disruption After National Air Traffic Control Failure
UK Bans Imports From Israeli Settlements and Expands Sanctions on Iran
British Chambers of Commerce Forecasts UK Growth of 1% as Investment Remains Weak
UK Suspends Local Government Reorganisation Decisions and Cancels Planned Shadow Authority Polls
UK Parliament Opens Inquiry Into Gaps in Climate Change Preparedness
Andy Burnham and Xi Jinping Hold Talks on Trade, Security and British Consular Cases
UK Joins France, Canada and Other Nations in Measures Against Israeli West Bank Settlements
UK Announces New Sanctions Targeting Iranian Nuclear and Military Networks
British Chambers of Commerce Calls for Business Rate Reform and Productivity Support
UK Farmers Warn Dry Summer Could Reduce Crop Yields and Push Up Food Prices
UK Rail Networks Hit by Widespread Delays After Major Signalling Failures
Matt Clifford Resigns as ARIA Chair After Conflict-of-Interest Scrutiny
UK and France Say Joint Border Operations Have Prevented More Than 48,000 Irregular Channel Crossings
UK Core Inflation Remains Above Expectations as Utility and Commodity Costs Stay Elevated
Jaguar Land Rover Considers Up to 4,000 UK Job Cuts Amid Automotive Industry Pressure
×